North American digital PCR (dPCR) and real-time PCR (qPCR) market is expected to grow at a CAGR of 8.0% during the forecast period. The region holds a considerable share in the global dPCR and qPCR market and is analyzed on the basis of the countries including the US and Canada. As per the World Economy Forum, North America comprises around 28% of the global economy in 2018. Huge funding for the development and commercialization of devices based on PCR technologies coupled with high per capita healthcare expenditure is a key factor to drive the growth of this regional market. For instance, in November 2018, Illumina Ventures had made an investment of around 17 million in Series A funding in a US-based digital PCR firm, Stilla Technologies to avail the funds to commercialize the Naica digital PCR system of the firm.

The increase in the mortality rate of cancer patients in North America plays a critical role in the R&D of personalized medicine for the treatment of the condition. According to the National Cancer Institute in 2017, an estimated expenditure for cancer care in the US was $147.3 billion. Molecular diagnostics is a highly personalized approach for the treatment of the different types of cancers. Therefore, the rising prevalence of cancer is contributing to the adoption of for molecular diagnostics technologies which in turn is expected to spur the growth of the dPCR and qPCR market in North America. Rising demand for rapid diagnostic tests and the significant presence of diagnostic laboratories along with the wide adoption rate of novel assay technologies are further anticipated to propel the growth of the dPCR and qPCR market in the region.

Agilent Technologies, Inc., Abbott Laboratories, Inc., Danaher Corp., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche AG, Merck KGaA, Becton Dickinson and Co., QIAGEN N.V., and Bio-Rad Laboratories, are the key players operating in the region. The growth strategies adopted by these players such as acquisitions, mergers, investment in R&D activities and product launches are estimated to have a positive impact on the growth of the PCR technologies such as dPCR and qPCR in the region. For instance, in September 2018, Danaher Corp. acquired the US-based, Integrated DNA Technologies, a provider of high-value consumables for genomics applications in molecular biology, qPCR, molecular diagnostics, and so on. With this acquisition Danaher corp. aims to expand its business in the genomics. 

Research Methodology

The market study of the North American dPCR and qPCR market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings authenticity in our reports.

Secondary Sources Include:

• Financial reports of companies involved in the market
• Whitepapers, research-papers, and news blogs
• Company websites and their product catalog

The report provides an in-depth analysis of pricing, market size, intended quality of the product preferred by consumers. It will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

1. North American dPCR and qPCR Market Research and Analysis, By Technology
2. North American dPCR and qPCR Market Research and Analysis, By Product
3. North American dPCR and qPCR Market Research and Analysis, By Application

The Report covers:

• Comprehensive research methodology of the North American dPCR and qPCR market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the North American dPCR and qPCR market.
• Insights about market determinants which are stimulating the North American dPCR and qPCR market.
• Detailed and extensive market segments with regional distribution of forecast revenues.
• Extensive profiles and recent developments of market players.